 |
 Video: What is a Stock Split?
|
|
|
| Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral biologic product candidates. Co.'s proprietary technology platform allows Co. to utilize existing natural cellular trafficking pathways to facilitate the transport of diverse therapeutic payloads across the epithelial barriers. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with rheumatoid arthritis. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects. According to our Applied Molecular Transport stock split history records, Applied Molecular Transport has had 0 splits. | |
|
Applied Molecular Transport (AMTI) has 0 splits in our Applied Molecular Transport stock split history database.
Looking at the Applied Molecular Transport stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Applied Molecular Transport shares, starting with a $10,000 purchase of AMTI, presented on a split-history-adjusted basis factoring in the complete Applied Molecular Transport stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/08/2020 |
|
| End date: |
12/28/2023 |
|
| Start price/share: |
$18.99 |
|
| End price/share: |
$0.26 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.62% |
|
| Average Annual Total Return: |
-69.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$138.54 |
|
| Years: |
3.56 |
|
|
|
|
|
